Galderma Nordic

Our History

	Differin ® Lotion 0.1% (acne) launch in the United States.
	Launch of Azzalure ® (glabellar lines) and Oracea ® in Europe. Vectical ® (psoriasis) launch in the United-States.
	Epiduo ® (acne) launch. Acquisition of CollaGenex Pharmaceuticals and its product Oracea ® (rosacea). Launch of Differin ® 0.1% in Japan.
	In-licensing of Ipsen's Botulinum Toxin Type A for Europe, Argentina and Brazil.
	Inauguration of the new research and preclinical development building in Sophia-Antipolis, France. Opening of a new production site in Hortolandia, Brazil. Clobex® Shampoo launch in the United-States and acquisition of Tri-Luma®.
	Launch of anti-acne treatment Differin®, Galderma’s first home-grown dermatology product.
	Galderma inaugurates its wholly-owned production plant in Alby-sur-Chéran, near Annecy in the French Alps.
	Galderma’s first affiliate opens for business in France, followed by a second in Italy. The International Dermatology Research Center focuses its efforts on prescription dermatology products.
	Nestlé and L'Oréal form a joint venture to become the world’s leading dermatology player. Galderma is born.
	L'Oréal creates its International Dermatology Research Center (CIRD) in Sophia-Antipolis, France, specializing in fundamental research into skin physiology.
	Nestlé acquires Alcon to strengthen its presence in the North American market.
	Acquisition of Owen by ophthalmology specialist Alcon, headquartered in Fort Worth, Texas.
	Creation of the Owen dermatology company in Dallas, Texas, USA.